StonvexLoading…
StonvexStonvexStonvexCore line items from HSTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $82.53M | $81.20M | $304.06M | $224.35M | $147.88M |
Operating Income | Not available | $7.51M | $20.24M | $17.83M | $10.26M |
Net Income | Not available | $5.91M | $18.34M | $15.81M | $5.39M |
EPS (Diluted) | $0.17 | $0.20 | $0.61 | $0.52 | $0.32 |
Total Assets | Not available | $527.44M | $520.37M | $499.93M | $500.15M |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $48.71M | $36.16M | $53.54M | $52.10M |
Free Cash Flow OCF − CapEx | Not available | $26.40M | $59.63M | $46.65M | $28.73M |
Shares Outstanding | Not available | 29.30M | 29.58M | 29.65M | 29.90M |